FDA Using GMP Head Count Method That May Shorten Compliance Schedules
This article was originally published in The Tan Sheet
Executive Summary
Despite industry opposition, FDA will likely stick with an approach to assessing a firm's size that would count some small or medium-sized dietary supplement firms as larger, significantly shortening their schedule to comply with dietary supplement good manufacturing practices, officials say